Speaker: Date: Topic
Joseph Ming Wah Li, MD, SFHM, FACP
Mar 30, 2016
New Drugs (2015) and Their Appropriate Use
Objectives of the Presentation
Participants should be able to:
- Discuss indications, uses, and potential side effects.
- Identify new molecular entities.
- Recognize drugs that generalists will see most often.
The Director of Medical Education and Committee Members have indicated they have no relevant financial interests or relationships to disclose. Faculty has indicated no relevant financial interests or relationships to disclose.
Responsibility for Content
The PowerPoint presentation, Take-Away points, Objectives, Disclosures, and Article links were sent by Medical Library Services and the CME Committee.
Diane E. Young, Information Specialist
Take-Away Points of the Presentation
1. PCSK9 is a protease which binds to the LDL receptor and leads to increased LDL blood levels. This is the mechanism of how inhibition of PCSK9 leads to LDL lowering in the bloodstream.
2. In patients with stable CAD without clinical heart failure, the addition of Ivabradine to standard therapy to decrease heart rate did not improve outcomes.
3. Sodium polystyrene sulfonate should not be given to patients with suspected ileus or bowel obstruction.